Elias Björnson
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 16
- Diet, Metabolism, and Disease 5
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 9
-
- Lipid metabolism and disorders 12
- Physiology top 10%
- Adipose Tissue and Metabolism 5
- Surgery top 10%
- Lipoproteins and Cardiovascular Health 16
-
- Liver Disease Diagnosis and Treatment 11
-
- Metabolism, Diabetes, and Cancer 5
Elias Björnson
45 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Endocrinology, Diabetes and Metabolism 630
- Cancer Research 270
- Cardiology and Cardiovascular Medicine 363
- Physiology 273
- Surgery 461
Countries citing papers authored by Elias Björnson
This map shows the geographic impact of Elias Björnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elias Björnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elias Björnson more than expected).
Fields of papers citing papers by Elias Björnson
This network shows the impact of papers produced by Elias Björnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elias Björnson. The network helps show where Elias Björnson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elias Björnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 2 | |
| 5 | Lipoprotein(a) Is Markedly More Atherogenic Than LDLbreakdown → | 2024 | 98 |
| 6 | 2024 | 13 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 5 | |
| 9 | Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank studybreakdown → | 2023 | 97 |
| 10 | 2023 | 11 | |
| 11 | 2022 | 22 | |
| 12 | 2021 | 8 | |
| 13 | 2021 | 7 | |
| 14 | 2020 | 19 | |
| 15 | 2020 | 50 | |
| 16 | 2020 | 18 | |
| 17 | 2017 | 16 | |
| 18 | 2016 | 19 | |
| 19 | 2015 | 61 | |
| 20 | 2015 | 113 |
About Elias Björnson
Elias Björnson is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 49 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers), Lipid metabolism and disorders (12 papers), Liver Disease Diagnosis and Treatment (11 papers), Cancer, Lipids, and Metabolism (9 papers), Diet, Metabolism, and Disease (5 papers), Adipose Tissue and Metabolism (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (630 citations), Cancer Research (270 citations) and Cardiology and Cardiovascular Medicine (363 citations). Elias Björnson has collaborated with scholars based in Sweden, Finland and United Kingdom. Frequent co-authors include Jan Borén, Marja‐Riitta Taskinen, Chris J. Packard, Martin Adiels, Adil Mardinoğlu, Niina Matikainen, Sanni Söderlund, Antti Hakkarainen, Stephen Burgess and Jens Nielsen.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.